Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00122889 · ClinicalTrials.gov registry record
Effects of Garlic Supplements on Drug Metabolism
A clinical trial, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT00122889: Completed study, sponsored by Fred Hutchinson Cancer Center.
NCT00122889 is a clinical trial that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00122889 has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study will determine whether garlic supplements affect the way certain drugs are processed in the body.
Interventions
- DRUG Garlic powder with high allicin content
- DRUG Garlic powder with low allicin content
- DRUG Garlic oil
- DRUG Aged garlic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2005-07 |
| Est. Completion | 2009-03 |
What the finished NCT00122889 record still lists
NCT00122889 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Garlic powder with high allicin content is the first listed.
NCT00122889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00122889 about?
NCT00122889 is a clinical study titled "Effects of Garlic Supplements on Drug Metabolism". This study will determine whether garlic supplements affect the way certain drugs are processed in the body.
What is the current status of trial NCT00122889?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2005-07. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00122889?
The interventions under investigation include: Garlic powder with high allicin content (DRUG), Garlic powder with low allicin content (DRUG), Garlic oil (DRUG), Aged garlic (DRUG).
Who is sponsoring clinical trial NCT00122889?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia